Shortage reports
Actual shortage:
58 (4%)
Anticipated shortage:
2 (0%)
Avoided shortage:
37 (3%)
Resolved:
1273 (93%)
1370
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
287 (99%)
Reversed:
2 (1%)
291
211 (13%)
11 (18%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2018-11-29 | 2019-06-11 | 67925 |
| PMS-IRBESARTAN | 300MG | TABLET | Resolved | 2025-11-10 | 2025-12-01 | 271432 |
| PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2023-08-10 | 2023-08-28 | 201548 |
| PMS-IRBESARTAN | 300MG | TABLET | Resolved | 2017-09-07 | 2018-04-19 | 21554 |
| PMS-IRBESARTAN | 150MG | TABLET | Resolved | 2017-09-07 | 2017-10-11 | 21551 |
| PMS-IRBESARTAN | 150MG | TABLET | Resolved | 2019-03-04 | 2019-09-12 | 77462 |
| PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2024-12-04 | 2024-12-20 | 244825 |
| PMS-IRBESARTAN | 300MG | TABLET | Resolved | 2019-03-04 | 2020-05-19 | 77465 |
| PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2017-04-20 | 2017-06-09 | 7373 |
| PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2023-10-02 | 2023-12-22 | 205611 |
| PMS-IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2022-11-11 | 2023-03-30 | 174390 |
| PMS-IRBESARTAN-HCTZ | 12.5MG 300MG | TABLET | Resolved | 2021-11-15 | 2023-04-06 | 149254 |
| PMS-IRBESARTAN-HCTZ | 12.5MG 300MG | TABLET | Actual shortage | 2023-04-06 | 2025-08-04 | 188954 |
| PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2019-06-28 | 2019-12-24 | 87971 |
| PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2017-09-07 | 2018-03-20 | 21562 |
| PMS-IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2025-02-05 | 2025-04-01 | 249588 |
| PMS-IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2017-03-24 | 2018-04-27 | 4213 |
| PMS-IRBESARTAN-HCTZ | 12.5MG 300MG | TABLET | Resolved | 2017-03-24 | 2017-09-19 | 4216 |
| PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2017-06-23 | 2017-12-18 | 13709 |
| PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2024-02-07 | 2024-05-24 | 218776 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4993 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4990 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6035 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6031 |
| ACET CODEINE 30 | 300MG 30MG | TABLET | Discontinued | 2018-02-22 | 2018-07-23 | 40586 |
| ACET CODEINE 60 | 300MG 60MG | TABLET | Discontinued | 2019-01-16 | 2019-01-17 | 72608 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 8MG 15MG 300MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117748 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Discontinued | 2017-10-12 | 2017-10-13 | 25698 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Discontinued | 2017-10-12 | 2017-10-13 | 25692 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 15MG 8MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117751 |
| ATORVASTATIN | 80MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 138001 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137982 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137995 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137986 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137992 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137998 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137989 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2020-07-23 | 2020-07-23 | 120976 |
| CHARCODOTE SUSP 200MG/ML | 200MG | SUSPENSION | Discontinued | 2020-06-16 | 2020-06-16 | 118017 |
| EGOZINC-HC | 0.5% 0.5% | OINTMENT | Discontinued | 2018-01-26 | 2018-01-26 | 37263 |